Neuronetics rises on upbeat 2025 revenue forecast

Neuronetics

04/03/2025 15:38

** Shares of Pennsylvania-based medtech firm Neuronetics STIM.O rise 8.2% to $4.61

** Company forecasts 2025 revenue between $145 million and $155 million, above analysts' estimate of $93.55 million, according to data compiled by LSEG

** Company, which offers its NeuroStar device to treat major depressive disorder (MDD), posts Q4 revenue of $22.49 million, beating analysts' estimates of $19.63 million

** In the last 12 months, STIM has fallen 41.5%

 (Reporting by Siddhi Mahatole)

 ((siddhi.mahatole@thomsonreuters.com))